Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma

被引:24
|
作者
Tarasova, V. D. [1 ]
Tuttle, R. M. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Serv Endocrinol, 1275 York Ave, New York, NY 10021 USA
关键词
Low risk thyroid cancer; papillary microcarcinoma; staging; BRAF V600E MUTATION; ACTIVE SURVEILLANCE; RADIOACTIVE IODINE; CARCINOMA; ASSOCIATION; RECURRENCE; STRATIFICATION; SURGERY; PROGNOSIS; IMPACT;
D O I
10.1016/j.clon.2016.12.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Each year, the proportion of thyroid cancer patients presenting with low risk disease is increasing. Moreover, the definition of low risk thyroid cancer is expanding and several histological subtypes beyond papillary microcarcinomas are now classified as low risk disease. This shift in the landscape of thyroid cancer presentation is forcing clinicians to critically re-evaluate whether or not traditional management paradigms that were effective in treating intermediate and high risk disease are applicable to these low risk patients. Here we review the definition of low risk disease, examine the various histological subtypes that are considered low risk in the 2015 American Thyroid Association guidelines for the management of thyroid nodules and thyroid cancer, and review our current approach to the management of these low risk tumours. (C) 2016 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
引用
收藏
页码:290 / 297
页数:8
相关论文
共 50 条
  • [1] RE: Management of Low-Risk Papillary Thyroid Microcarcinoma
    Baek, Jung Hwan
    Na, Dong Gyu
    Park, Hye Sun
    KOREAN JOURNAL OF RADIOLOGY, 2017, 18 (02) : 408 - 409
  • [2] Clinical management of low-risk papillary thyroid microcarcinoma
    Masaki, Chie
    Sugino, Kiminori
    Ito, Koichi
    MINERVA ENDOCRINOLOGY, 2021, 46 (04): : 413 - 427
  • [3] Current management of papillary thyroid microcarcinoma in Canada
    Merdad, Mazin
    Eskander, Antoine
    De Almeida, John
    Freeman, Jeremy
    Rotstein, Lorne
    Ezzat, Shereen
    Sawka, Anna M.
    Goldstein, David P.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2014, 43 : 32
  • [4] Current management of papillary thyroid microcarcinoma in Canada
    Mazin Merdad
    Antoine Eskander
    John De Almeida
    Jeremy Freeman
    Lorne Rotstein
    Shereen Ezzat
    Anna M Sawka
    David P Goldstein
    Journal of Otolaryngology - Head & Neck Surgery, 43
  • [5] Papillary thyroid microcarcinoma: current controversies and management
    Lopez, Fernando
    Garcia-Cabo, Patricia
    Fernandez-Vanes, Laura
    Coca-Pelaz, Andres
    Pablo Rodrigo, Juan
    Luis Llorente, Jose
    REVISTA ORL, 2021, 12 (04) : 325 - 340
  • [6] Conservative Surveillance Management of Low-Risk Papillary Thyroid Microcarcinoma
    Miyauchi, Akira
    Ito, Yasuhiro
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 215 - +
  • [7] Papillary microcarcinoma of the thyroid gland: current controversies and management
    Rovira, Aleix
    Nixon, Iain J.
    Simo, Ricard
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2019, 27 (02): : 110 - 116
  • [8] Management of Papillary Thyroid Microcarcinoma
    Brito, Juan P.
    Hay, Ian D.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 199 - +
  • [9] Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
    Jeon, Min Ji
    Kim, Won Gu
    Kim, Tae Yong
    Shong, Young Kee
    Kim, Won Bae
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (04) : 717 - 724
  • [10] Diagnosis and treatment of low-risk papillary thyroid microcarcinoma
    Moon, Jae Hoon
    Park, Young Joo
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2018, 61 (04): : 232 - 240